￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Differences between Entrectinib and Larotrectinib and Medication Selection Guide

2026-02-01 22:25:32

Check Details
Whether acalatinib is a targeted drug and an introduction to its mechanism of action

2026-02-01 22:25:32

Check Details
What diseases does ibrutinib capsules mainly treat and its scope of application?

2026-02-01 22:25:32

Check Details
Analysis of the effectiveness and cost-effectiveness of the Bangladeshi version of ruxolitinib tablets (JAKAVI)

2026-02-01 22:25:32

Check Details
Clinical efficacy and medication regimen of clofazimine in the treatment of pulmonary tuberculosis

2026-02-01 22:25:32

Check Details
Analysis of whether gosatuzumab (Todavi) is a purely targeted drug

2026-02-01 22:25:32

Check Details
Treatment regimen and effect analysis of amivantamab combined with lazetinib

2026-02-01 22:25:32

Check Details
Which company develops and produces margetuximab?

2026-02-01 22:25:32

Check Details
Introduction to relevant information on Dacomitinib (Dacomitinib) Tablets obtaining the drug registration certificate

2026-02-01 22:25:32

Check Details
Brigatinib (Brigatinib) Takeda brand price and introduction to regular purchase channels

2026-02-01 22:25:32

Check Details
Common side effects of Entrectinib and how to effectively deal with them

2026-02-01 22:25:32

Check Details
Whether acalatinib has been officially included in the medical insurance catalog and its explanation

2026-02-01 22:25:32

Check Details
Category
相关知识